Literature DB >> 1738205

Persistent infection of normal mice with human immunodeficiency virus.

C Locardi1, P Puddu, M Ferrantini, E Parlanti, P Sestili, F Varano, F Belardelli.   

Abstract

In this article, we report the establishment of persistent HIV type 1 infection of normal Swiss mice after a single intraperitoneal injection with high-producing HIV-infected U937 cells. Anti-HIV antibodies were found more than 500 days after the original injection, and p24 antigenemia was detected in approximately 50% of the mice. By polymerase chain reaction (PCR) techniques, HIV-specific gag and env sequences were detected in DNA samples from peripheral blood mononuclear cells (PBMC) and peritoneal cells of seropositive mice 300 to 500 days after inoculation with HIV-infected cells. These DNA samples did not contain human DNA sequences, as determined by PCR analysis using primers and the probe for the HLA-DQ alpha gene. Low levels of p24 and detectable human reverse transcriptase activity were found in cultures of PBMC and peritoneal macrophages. Cocultivation of PBMC, peritoneal cells, and spleen cells with human uninfected U937 or CEM (a T lymphoma cell line) cells resulted in HIV infection of the target cells, as determined by PCR analysis and/or p24 assays. The intravenous injection of untreated Swiss mice with the PBMC from PCR-positive mice resulted in the development of an increasing antibody response to HIV in the recipient animals. Together these results indicate that cells from seropositive Swiss mice were persistently infected with HIV and were capable of producing infectious virus. The development of persistent HIV infection in an immunocompetent mouse may represent the starting point for further studies aimed at defining the host mechanisms involved in the restriction of virus replication, defining the pathogenesis of HIV infection, and testing antiviral compounds and vaccines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738205      PMCID: PMC240902     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice.

Authors:  J Leonard; J S Khillan; H E Gendelman; A Adachi; S Lorenzo; H Westphal; M A Martin; M S Meltzer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

2.  AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts.

Authors:  J A Levy; C Cheng-Mayer; D Dina; P A Luciw
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

3.  Role of endogenous alpha/beta interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice.

Authors:  M Ferrantini; F Belardelli; C Locardi
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1.

Authors:  G Filice; P M Cereda; P Orsolini; L Soldini; E Romero; E G Rondanelli
Journal:  Microbiologica       Date:  1989-01

5.  Beta interferon subtype 1 induction by tumor necrosis factor.

Authors:  H Jacobsen; J Mestan; S Mittnacht; C W Dieffenbach
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

6.  The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

Authors:  N R Landau; M Warton; D R Littman
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  Infection of the SCID-hu mouse by HIV-1.

Authors:  R Namikawa; H Kaneshima; M Lieberman; I L Weissman; J M McCune
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

8.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

9.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Infection of rabbits with human immunodeficiency virus 1. A small animal model for acquired immunodeficiency syndrome.

Authors:  H Kulaga; T Folks; R Rutledge; M E Truckenmiller; E Gugel; T J Kindt
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  5 in total

1.  Transgenic mice expressing human HIV receptors become persistently recipient of HIV DNA after injection with infected human cell lines.

Authors:  L Simeoni; P Forte; A Aiuti; A Candido; A F Campese; G Fedele; F Di Tommaso; M Navarra; A Fantoni
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

2.  T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.

Authors:  P Rizza; S M Santini; M A Logozzi; C Lapenta; P Sestili; G Gherardi; R Lande; M Spada; S Parlato; F Belardelli; S Fais
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis.

Authors:  Santhi Gorantla; Edward Makarov; Jennifer Finke-Dwyer; Antonio Castanedo; Adelina Holguin; Catherine L Gebhart; Howard E Gendelman; Larisa Poluektova
Journal:  Am J Pathol       Date:  2010-11-18       Impact factor: 4.307

4.  Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus.

Authors:  S Reina; P Markham; E Gard; F Rayed; M Reitz; R C Gallo; O E Varnier
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  Tissue-specific expression of human CD4 in transgenic mice.

Authors:  F P Gillespie; L Doros; J Vitale; C Blackwell; J Gosselin; B W Snyder; S C Wadsworth
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.